Plasma Cytokine Predictors of Tuberculosis Recurrence in Antiretroviral-Treated HIV-infected Individuals from Durban, South Africa.

Sivro A. McKinnon LR, Yende-Zuma N, Gengiah S, Samsunder N, Abdool Karim SS, Naidoo K.
Clinical Infectious Diseases 2017; 65(5): 819-826.

Read publication
Brief Report: Selection of HIV-1 Variants with Higher Transmission Potential by 1% Tenofovir Gel Microbicide.

Ngandu NK, Carlson JM, Chopera DR, Ndabambi N, Abdool Karim Q, Abdool Karim S, Williamson C.
JAIDS 2017; 76(1):43-47.

Read publication
Sexual partnership age pairings and risk of HIV acquisition in rural South Africa.

Akullian A, Bershteyn A, Klein D, Vandormael A, Bärnighausen T, Tanser F.
AIDS 2017; 31(12):1755-1764.

Read publication
Optimal timing of antiretroviral treatment initiation in HIV-positive children and adolescents: a multiregional analysis from Southern Africa, West Africa and Europe.

Schomaker M, Leroy V, Wolfs T, Technau KG, Renner L, Judd A, Sawry S, Amorissani-Folquet M, Noguera-Julian A, Tanser F, Eboua F.
International Journal of Epidemiology 2017; 46(2):453-465.

Read publication
Proximity to healthcare clinic and depression risk in South Africa: geospatial evidence from a nationally representative longitudinal study.

Tomita A, Vandormael AM, Cuadros D, Slotow R, Tanser F, Burns JK.
Social Psychiatry and Psychiatric Epidemiology 2017; 52(8): 1023-1030.

Read publication
Relapse, re-infection and mixed infections in tuberculosis disease.

McIvor A, Koornhof H, Kana BD.
Pathogens and Disease 2017; 75(3): 1-16. doi: 10.1093/femspd/ftx020.

Read publication

Centre for the AIDS Programme of Research in South Africa

CAPRISA was created in 2001 and formally established in 2002 under the NIH-funded Comprehensive International Program of Research on AIDS (CIPRA) by five partner institutions; University of KwaZulu-Natal, University of Cape Town, University of Western Cape, National Institute for Communicable Diseases, and Columbia University in New York. CAPRISA is a designated UNAIDS Collaborating Centre for HIV Prevention Research. The main goal of CAPRISA is to undertake globally relevant and locally responsive research that contributes to understanding HIV pathogenesis, prevention and epidemiology as well as the links between tuberculosis and AIDS care.